Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Single-dose Ketamine to Reduce Pain Severity, Depressive Symptoms and the Need for Opiates Both During and After Emergency Department Care


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03436121

Organisation Name: University of Pittsburgh

Overal Status: Withdrawn

Start Date: December 2019

Last Update: February 11, 2020

Lead Sponsor: Maria Pacella

Brief Summary: In this proposal, the investigators will determine if a single dose of intravenous (IV) ketamine (in combination with midazolam) reduces pain severity, depressive symptoms and need for opiate analgesics both in the ED and in the acute recovery period after ED discharge. The investigators will compare the ketamine arm to an active placebo-controlled arm (with midazolam).

Conditions:
  • Acute Pain
  • Depression


Total execution time in seconds: 0.16056704521179